altoneuroscience.comHealthcareFounded: 2019Funding to Date: $101.8MM
Alto Neurosciences is a biopharma company that uses biomarkers of the brain to understand prospective drug therapies for psychiatric care of patients. Alto Neurosciences specializes in precision medicine, and has established a pipeline of treatments for various mental health conditions such as post-traumatic stress disorders (PTSD) and depression.
View Enterprise Value for Alto Neuroscience.